Pseudomonas Aeruginosa
Showing 1 - 25 of 34
Pseudomonas Aeruginosa Infections Among COVID-19 Intensive Care
Not yet recruiting
- Pseudomonas Aeruginosa
- COVID-19
- Observation
-
Vandœuvre-lès-Nancy, Lorraine, FranceNancy University Hospital
Nov 17, 2023
Bronchiectasis, Cystic Fibrosis, Pseudomonas Aeruginosa Trial (Ceftolozane/tazobactam)
Not yet recruiting
- Bronchiectasis
- +3 more
- (no location specified)
Sep 6, 2023
Cystic Fibrosis Lung, Respiratory Infections, Recurrent, Chronic, Pseudomonas Aeruginosa Trial in Australia, United States
Not yet recruiting
- Cystic Fibrosis Lung
- +2 more
- RSP-1502
- Tobramycin inhalation solution
-
Tucson, Arizona
- +14 more
Aug 24, 2023
Patients With Infection by Resistant Microorganism
Enrolling by invitation
- Pneumonia
- +10 more
- Pathogen resistant phenotype
-
Sevilla, SpainHospital Universitario Virgen Macarena
May 18, 2023
Non-cystic Fibrosis Bronchiectasis, Pseudomonas Aeruginosa, Lung Infection Trial in Farmington, Tyler (AP-PA02, Placebo)
Recruiting
- Non-cystic Fibrosis Bronchiectasis
- +2 more
- AP-PA02
- Placebo
-
Farmington, Connecticut
- +1 more
Jan 13, 2023
Cystic Fibrosis, Pseudomonas Aeruginosa, Pseudomonas Trial in United States (AP-PA02, Placebo)
Active, not recruiting
- Cystic Fibrosis
- +4 more
- AP-PA02
- Placebo
-
Los Angeles, California
- +19 more
Dec 20, 2022
Efflux Pump and Virulence Factors Genes in Pseudomonas
Not yet recruiting
- Pseudomonas Aeruginosa
- culture on cetrimide agar
- +3 more
- (no location specified)
Nov 29, 2022
Multidrug Resistant Bacterial Infection, Enterobacteriaceae Infections, Pseudomonas Aeruginosa Trial in Philadelphia (PMT)
Not yet recruiting
- Multidrug Resistant Bacterial Infection
- +4 more
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Nov 17, 2022
During Pseudomonas Aeruginosa Ventilator Acquired Pneumonia
Completed
- Pseudomonas Aeruginosa
- Ventilation Acquired Pneumonia
-
Grenoble, Isère, FranceMedical ICU of Universitary Hospital of Grenoble
Nov 7, 2022
Isolation of Human Recombinant Therapeutic Monoclonal
Recruiting
- Pseudomonas Aeruginosa
- Multi-antibiotic Resistance
- Isolation of anti-Pseudomonas antibodies from type B lymphocytes
-
Grenoble, FranceChu Grenoble Alpes
May 6, 2022
Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.
Recruiting
- Pseudomonas Aeruginosa
- +2 more
-
Jakarta, Indonesia
- +2 more
Mar 22, 2022
Carbapenem-Resistant Enterobacteriaceae Infection, Bloodstream Infection, Severe Infection Trial in Brazil (Duration of therapy)
Recruiting
- Carbapenem-Resistant Enterobacteriaceae Infection
- +9 more
- Duration of therapy
-
Feira De Santana, Bahia, Brazil
- +18 more
Jan 27, 2022
Pseudomonas Aeruginosa, Pneumonia, Hematologic Malignancy Trial in New York (Ceftolozane / Tazobactam Injection)
Suspended
- Pseudomonas Aeruginosa
- +2 more
- Ceftolozane / Tazobactam Injection
-
New York, New YorkWeill Cornell Medicine
Jan 25, 2022
Pseudomonas Aeruginosa, Cystic Fibrosis Trial in Tallin, Yaroslavl (Tobramycin inhalation powder)
Completed
- Pseudomonas Aeruginosa
- Cystic Fibrosis
- Tobramycin inhalation powder
-
Tallin, Estonia
- +1 more
May 7, 2021
Pulmonary Infections, Pseudomonas Aeruginosa Trial in Worldwide (Tobramycin inhalation powder)
Completed
- Pulmonary Infections
- Pseudomonas Aeruginosa
- Tobramycin inhalation powder
-
Pleven, Bulgaria
- +16 more
May 6, 2021
Pseudomonas Aeruginosa Biofilms in Exacerbations in
Recruiting
- Bronchiectasis
- +3 more
- Microbial biofilm diagnose
-
Barcelona, SpainHospital Clinic de Barcelona
Mar 16, 2021
Pseudomonas Aeruginosa Trial in Worldwide (MEDI3902, Placebo)
Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa, Pseudomonas Aeruginosa, Pseudomonas Infections Trial
Unknown status
- Patients With Complicated Urinary Tract Infections Caused by P. Aeruginosa
- +3 more
- Ftortiazinon (tablets 300 mg) 1/2 dose +placebo+ Maxipim
- +2 more
-
Saint Petersburg, Russian Federation
- +4 more
Jan 13, 2021
COPD, Respiratory Tract Infections, Pseudomonas Aeruginosa Trial in Hellerup, Hillerød (Piperacillin/tazobactam, Ciprofloxacin)
Unknown status
- COPD
- +2 more
-
Hellerup, Copenhagen, Denmark
- +1 more
Jan 28, 2020
Methicillin-resistant Staphylococcus Aureus, Clostridium Difficile, Pseudomonas Aeruginosa Trial in Baltimore, Philadelphia
Not yet recruiting
- Methicillin-resistant Staphylococcus Aureus
- +2 more
-
Baltimore, Maryland
- +1 more
Nov 20, 2019
Cross Transmissions of Pseudomonas Aeruginosa Between Children
Unknown status
- Cystic Fibrosis
- +2 more
-
Brussels, BelgiumHôpital Universitaire Des Enfants Reine Fabiola
Apr 9, 2019
Ceftolozane-tazobactam for MDR Pseudomonas Infections
Unknown status
- Pseudomonas Infections
- Pseudomonas Aeruginosa
-
Philadelphia, PennsylvaniaTemple University, School of Pharmacy
Apr 17, 2018
Cystic Fibrosis, Infection, Pseudomonas Aeruginosa Trial in Uppsala (Anti-pseudomonas IgY gargle)
Completed
- Cystic Fibrosis
- +2 more
- Anti-pseudomonas IgY gargle
-
Uppsala, SwedenCystic fibrosis centre,Children´s University Hospital
Aug 31, 2016
Alternating Inhaled Antibiotic Therapies
Completed
- Cystic Fibrosis
- Pseudomonas Aeruginosa
-
Indianapolis, IndianaIndiana University
Nov 5, 2015
The Carrier Rates of Pseudomonas Aeruginosa in Family Members of
Completed
- Pseudomonas Aeruginosa
- Cystic Fibrosis
-
Syracuse, New YorkSUNY Upstate Medical University
May 29, 2015